SARS-CoV2: Diagnostic tests available to the clinician

Hell J Nucl Med. 2020 May-Aug:23 Suppl:8-14.

Abstract

On December 2019, a new coronavirus disease (COVID-19) emerged in China and spread worldwide, causing acute severe respiratory syndrome. Due to the increased transmission rate of the virus, it became of great importance the early diagnosis of the disease. The coronavirus pandemic led to the development of numerous tests in order to mass screening population for active viral load and for the identification of antibodies for epidemiological purposes. This review summarizes the different diagnostic tests available to the clinicians for the diagnosis and follow up of the SARS COV-2 infections.

Publication types

  • Review

MeSH terms

  • COVID-19
  • Cell Culture Techniques / methods
  • Coronavirus Infections / blood
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / diagnostic imaging
  • Humans
  • Immunoassay / methods
  • Immunoassay / standards
  • Molecular Diagnostic Techniques / methods*
  • Molecular Diagnostic Techniques / standards
  • Pandemics
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / diagnostic imaging
  • Radiography, Thoracic / methods*
  • Radiography, Thoracic / standards
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Reverse Transcriptase Polymerase Chain Reaction / standards
  • Sensitivity and Specificity
  • Serologic Tests / methods
  • Serologic Tests / standards